Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

NCT00246597 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.

NCT NCT00246597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00246597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer
Lead sponsor
Ortho Biotech Products, L.P.
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2002
Completion date
June 30, 2004
Enrollment
37 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, breast neoplasms, chemotherapy, adjuvant, hemoglobins, quality of life